Hepatitis E Virus (HEV) Seroprevalence in the general population of the Republic of Korea in 2007-2009: a nationwide cross-sectional study

被引:17
|
作者
Yoon, Youngsil [1 ]
Jeong, Hye Sook [1 ]
Yun, Haesun [1 ]
Lee, Hyeokjin [1 ]
Hwang, Yoo-Sung [2 ]
Park, Bohyun [2 ]
Lee, Chae Jin [3 ]
Lee, Sangwon [1 ]
Hyeon, Ji-Yeon [1 ]
机构
[1] Korea Ctr Dis Control & Prevent, Div Vaccine Res, Korea Natl Inst Hlth, Cheongju 363951, Chungcheongbuk, South Korea
[2] Neodin Med Inst, Seoul 133170, South Korea
[3] Korea Ctr Dis Control & Prevent, Div Infect Dis, Cheongju 363951, Chungcheongbuk, South Korea
来源
BMC INFECTIOUS DISEASES | 2014年 / 14卷
关键词
Hepatitis E virus; Seroprevalence; National survey; Republic of Korea; NUTRITION EXAMINATION SURVEY; RISK-FACTORS; DEVELOPED-COUNTRIES; UNITED-STATES; BLOOD-DONORS; INFECTION; PREVALENCE; ANTIBODIES; SWINE; JAPAN;
D O I
10.1186/1471-2334-14-517
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: Hepatitis E virus (HEV) is an emerging pathogen associated with endemic and acute viral hepatitis. In this study, we investigate the HEV seroprevalence and putative risk factors by a nationwide cross-sectional study in the Republic of Korea. Methods: The prevalence of anti-HEV antibody was investigated in 2,450 serum samples collected in fourth Korea National Health and Nutrition Examination Survey. In addition, epidemiological information on possible risk factors including gender, age, education, occupation, and residence location for exposure to HEV was obtained. Results: The frequency of anti-EIA reactive sample was 5.9% (144/2450). The individuals in groups with male, older age, low education level and living in rural or coastal regions had high seroprevalence estimates (P <= 0.001). In addition, seroprevalence was significantly higher among individuals with self-identified skilled agricultural, forestry, and fishery workers (31.3%, P < 0.001). Conclusions: This study provides valuable data that could be used to investigate associations of HEV seroprevalence and putative risk factors by a nationwide cross-sectional study. The high HEV seroprevalence of skilled agricultural, forestry, and fishery workers and individuals lived in coastal and rural area indicated that zoonotic transmission is an important risk factor for HEV infection in the republic of Korea. Further studies that include detailed and continuous nationwide surveys are required to identify unrecognized risk factors and to monitor the HEV infection prevalence.
引用
收藏
页数:6
相关论文
共 50 条
  • [1] Hepatitis E Virus (HEV) Seroprevalence in the general population of the Republic of Korea in 2007–2009: a nationwide cross-sectional study
    Youngsil Yoon
    Hye Sook Jeong
    Haesun Yun
    Hyeokjin Lee
    Yoo-Sung Hwang
    Bohyun Park
    Chae Jin Lee
    Sangwon Lee
    Ji-Yeon Hyeon
    BMC Infectious Diseases, 14
  • [2] Seroprevalence of anti-hepatitis E virus (HEV) in a Korean population: comparison of two commercial anti-HEV assays
    Park, Hyun Kyung
    Jeong, Sook-Hyang
    Kim, Jin-Wook
    Woo, Byung-Hyun
    Lee, Dong Ho
    Kim, Hyun Young
    Ahn, Soyeon
    BMC INFECTIOUS DISEASES, 2012, 12
  • [3] Hepatitis E Virus Seroprevalence in Austrian Adults: A Nationwide Cross-Sectional Study among Civilians and Military Professionals
    Lagler, Heimo
    Poeppl, Wolfgang
    Winkler, Heidi
    Herkner, Harald
    Faas, Angelus
    Mooseder, Gerhard
    Burgmann, Heinz
    PLOS ONE, 2014, 9 (02):
  • [4] Cross-sectional study of hepatitis E virus (HEV) circulation in Italian pig farms
    Ianiro, Giovanni
    Pavoni, Enrico
    Aprea, Giuseppe
    Romantini, Romina
    Alborali, Giovanni Loris
    D'Angelantonio, Daniela
    Garofolo, Giuliano
    Scattolini, Silvia
    De Sabato, Luca
    Magistrali, Chiara Francesca
    Burow, Elke
    Ostanello, Fabio
    Smith, Richard Piers
    Di Bartolo, Ilaria
    FRONTIERS IN VETERINARY SCIENCE, 2023, 10
  • [5] Hepatitis E Virus (HEV) in Makkah, Saudi Arabia: A Population-Based Seroprevalence Study
    El-Daly, Mai M.
    Al-Raddadi, Rajaa
    Alharbi, Amany
    Azhar, Abdulrahman E.
    Khallaf, Amjed M.
    Hassan, Ahmed M.
    Alwafi, Osama M.
    Shabouni, Omaima I.
    Alandijany, Thamir A.
    Li, Tian-Cheng
    El-Kafrawy, Sherif A.
    Zumla, Alimuddin
    Azhar, Esam I.
    VIRUSES-BASEL, 2023, 15 (02):
  • [6] Seroprevalence of hepatitis E virus differs in Dutch and first generation migrant populations in Amsterdam, the Netherlands: a cross-sectional study
    Sadik, S.
    van Rijckevorsel, G. G. C.
    van Rooijen, M. S.
    Sonder, G. J. B.
    Bruisten, S. M.
    BMC INFECTIOUS DISEASES, 2016, 16
  • [7] Seroprevalence and risk factors for hepatitis E virus infection in the Romanian adult population: a cross-sectional study in a tertiary hospital
    Gheorghita, Valeriu
    Stefan, Ion
    Olaru, Ioana Diana
    Radu, Adelina Maria
    Sandulescu, Oana
    Streinu-Cercel, Anca
    Streinu-Cercel, Adrian
    REVISTA ROMANA DE MEDICINA DE LABORATOR, 2019, 27 (02): : 199 - 208
  • [8] Hepatitis E virus seroprevalence among the general population in a livestock-dense area in the Netherlands: a cross-sectional population-based serological survey
    van Gageldonk-Lafeber, Arianne B.
    van der Hoek, Wim
    Borlee, Floor
    Heederik, Dick J. J.
    Mooi, Sofie H.
    Maassen, Catharina B. M.
    Yzermans, C. Joris
    Rockx, Barry
    Smit, Lidwien A. M.
    Reimerink, Johan H. J.
    BMC INFECTIOUS DISEASES, 2017, 17
  • [9] Seroprevalence of Hepatitis E virus in children and adolescents living in urban Bogota: An explorative cross-sectional study
    Villalobos, Nathalie Veronica Fernandez
    Kessel, Barbora
    Paez, Johanna Carolina Torres
    Stroempl, Julia
    Kerrinnes, Tobias
    Restrepo, Fernando Pio de la Hoz
    Strengert, Monika
    Krause, Gerard
    FRONTIERS IN PUBLIC HEALTH, 2023, 11
  • [10] Seroprevalence of hepatitis A virus in a cross-sectional study in Mexico Implications for hepatitis A vaccination
    Lazcano-Ponce, Eduardo
    Conde-Gonzalez, Carlos
    Rojas, Rosalba
    DeAntonio, Rodrigo
    Romano-Mazzotti, Luis
    Cervantes, Yolanda
    Ortega-Barria, Eduardo
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2013, 9 (02) : 375 - 381